Last reviewed · How we verify
GX-H9
At a glance
| Generic name | GX-H9 |
|---|---|
| Sponsor | Genexine, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency (PHASE2)
- A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GX-H9 CI brief — competitive landscape report
- GX-H9 updates RSS · CI watch RSS
- Genexine, Inc. portfolio CI